<?xml version="1.0" encoding="UTF-8" standalone="yes"?>
<References xsi:schemaLocation="http://www.iedb.org/schema/CurationSchema http://beta.iedb.org/schema/Curation.xsd" xmlns="http://www.iedb.org/schema/CurationSchema" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">
    <Reference>
        <ReferenceId>560</ReferenceId>
        <DateLastUpdated>2020-10-11-07:00</DateLastUpdated>
        <Article>
            <PubmedId>7517550</PubmedId>
            <Abstract>We describe here the 1.7-A resolution structure of a single-chain antibody variable domain (scFv) molecule, based on the carbohydrate-binding antibody Se155-4, complexed with the trisaccharide ligand alpha-D-Gal(1--&gt;2)[alpha-D-Abe(1--&gt;3)]alpha-D-Manp1--&gt;OMe, where Abe is abequose. The scFv expressed in Escherichia coli has the variable region light chain to heavy chain polarity with the domains connected by a 19-residue linker. Although the linker is partially disordered in the crystal, the packing of the molecules suggests a monomeric state of the scFv. The carbohydrate adopts a different conformation about the Man-Gal linkage than was observed previously in the Fab-trisaccharide complex. Instead of a direct hydrogen bond between O2Abe and O2Gal, these two atoms are bridged by a water molecule in the present complex.</Abstract>
            <ArticleYear>1994</ArticleYear>
            <ArticlePages>6423-7</ArticlePages>
            <ArticleTitle>Structure of a single-chain antibody variable domain (Fv) fragment complexed with a carbohydrate antigen at 1.7-A resolution.</ArticleTitle>
            <Authors>
                <Author>
                    <LastName>Zdanov</LastName>
                    <ForeName>A</ForeName>
                </Author>
                <Author>
                    <LastName>Li</LastName>
                    <ForeName>Y</ForeName>
                </Author>
                <Author>
                    <LastName>Bundle</LastName>
                    <ForeName>D R</ForeName>
                </Author>
                <Author>
                    <LastName>Deng</LastName>
                    <ForeName>S J</ForeName>
                </Author>
                <Author>
                    <LastName>MacKenzie</LastName>
                    <ForeName>C R</ForeName>
                </Author>
                <Author>
                    <LastName>Narang</LastName>
                    <ForeName>S A</ForeName>
                </Author>
                <Author>
                    <LastName>Young</LastName>
                    <ForeName>N M</ForeName>
                </Author>
                <Author>
                    <LastName>Cygler</LastName>
                    <ForeName>M</ForeName>
                </Author>
            </Authors>
            <Affiliations>Biotechnology Research Institute, National Research Council of Canada, Montreal, PQ.</Affiliations>
            <ArticleChemicalList>Bacterial Outer Membrane Proteins;Epitopes;Immunoglobulin Fab Fragments;Immunoglobulin G;Immunoglobulin Variable Region;Lipopolysaccharides;Oligosaccharides;Recombinant Fusion Proteins</ArticleChemicalList>
            <ArticleMeshHeadingsList>Amino Acid Sequence; Animals; Bacterial Outer Membrane Proteins(genetics); Carbohydrate Conformation; Carbohydrate Sequence; Cloning, Molecular; Crystallography, X-Ray(methods); Epitopes(metabolism); Escherichia coli; Genes, Immunoglobulin; Immunoglobulin Fab Fragments(chemistry); Immunoglobulin G(chemistry); Immunoglobulin Variable Region(chemistry; genetics; metabolism); Lipopolysaccharides(immunology); Mice; Molecular Sequence Data; Oligosaccharides(metabolism); Protein Conformation; Recombinant Fusion Proteins(biosynthesis; chemistry); Salmonella(immunology)</ArticleMeshHeadingsList>
            <Journal>
                <Volume>91</Volume>
                <Issue>14</Issue>
                <Title>Proceedings of the National Academy of Sciences of the United States of America</Title>
                <Issn>0027-8424</Issn>
                <MedlineTa>Proc Natl Acad Sci U S A</MedlineTa>
            </Journal>
        </Article>
        <Epitopes>
            <Epitope>
                <EpitopeName>trisaccharide α-D-Gal(1--&gt;2)[α-D-Abe(1--&gt;3)]α-D-Man&amp;p1--&gt;Ome</EpitopeName>
                <EpitopeStructure>
                    <FragmentOfANaturalNonSequenceMolecule>
                        <ChemicalType>Carbohydrate fragment</ChemicalType>
                        <Molecule>
                            <ChEBIId>CHEBI:59319</ChEBIId>
                        </Molecule>
                        <SourceMolecule>
                            <ChEBIId>CHEBI:16412</ChEBIId>
                        </SourceMolecule>
                        <SourceOrganismId>29477</SourceOrganismId>
                    </FragmentOfANaturalNonSequenceMolecule>
                </EpitopeStructure>
                <LocationOfData>Materials and Methods</LocationOfData>
                <EpitopeId>127517</EpitopeId>
                <EpitopeEvidenceCode>Exact match to reference information</EpitopeEvidenceCode>
                <EpitopeStructureDefines>Exact Epitope</EpitopeStructureDefines>
                <EpitopeComments>The epitope is part of the O-PS repeating unit of Salmonella type B LPS.</EpitopeComments>
                <Assays>
                    <BCell>
                        <LocationOfData>Table 1, Figures 1, 2, 3 and PDB 1MFA</LocationOfData>
                        <BCellId>4726</BCellId>
                        <Immunization>
                            <HostOrganism>
                                <OrganismId>10000000</OrganismId>
                            </HostOrganism>
                            <FirstInVivoProcess>
                                <InVivoProcessType>Administration in vivo</InVivoProcessType>
                                <ImmunogenObject>
                                    <EpitopeRelation>Source Organism</EpitopeRelation>
                                    <Object>
                                        <Organism>
                                            <SubType>Organism</SubType>
                                            <SourceOrganismId>29477</SourceOrganismId>
                                        </Organism>
                                    </Object>
                                </ImmunogenObject>
                                <ImmunogenReferenceName>Phenol-killed bacterial cells</ImmunogenReferenceName>
                                <ImmunogenEvidenceCode>Exact match to reference information</ImmunogenEvidenceCode>
                                <Route>Intraperitoneal (i.p.)</Route>
                                <DoseSchedule>8 doses of 10&lt;sup&gt;8&lt;/sup&gt; killed cells</DoseSchedule>
                            </FirstInVivoProcess>
                            <ImmunizationComments>Six injections were given 2 weeks apart, the 7th and 8th injections were given after periods of 3 weeks from the previous injection. The immunization detail are found in Bundle et al. (1994) Biochemistry 33(17): 5172-5182 [PMID:7513555].</ImmunizationComments>
                        </Immunization>
                        <AssayInformation>
                            <AssayTypeId>436</AssayTypeId>
                            <QualitativeMeasurement>Positive</QualitativeMeasurement>
                            <QuantitativeMeasurement>1.7</QuantitativeMeasurement>
                            <MeasurementInequality>=</MeasurementInequality>
                            <AssayComments>Se155-4 scFv is specific for an oligosaccharide epitope of Salmonella serogroup B LPS. The antigen was synthesized with an O-methyl group to preserve the alpha isomer of the anomeric carbon at terminal mannose.</AssayComments>
                        </AssayInformation>
                        <AssayedAntibody>
                            <AssayedAntibodySourceMaterial>Purified Immunoglobulin</AssayedAntibodySourceMaterial>
                            <AssayedAntibodyImmunoglobulinDomain>scFv</AssayedAntibodyImmunoglobulinDomain>
                            <AssayedAntibodyPurificationStatus>Monoclonal</AssayedAntibodyPurificationStatus>
                            <AssayedAntibodyName>Se155-4 scFv</AssayedAntibodyName>
                            <AssayedAntibodyHeavyChainType>IgG1</AssayedAntibodyHeavyChainType>
                            <AssayedAntibodyLightChainType>Lambda</AssayedAntibodyLightChainType>
                            <AssayedAntibodyObject>
                                <MultiChainMolecule>
                                    <ChemicalType>Multi-Chain protein</ChemicalType>
                                    <MoleculeName>Se155-4</MoleculeName>
                                    <Chain1>
                                        <Molecule>
                                            <GenBankId>1MFA_H</GenBankId>
                                        </Molecule>
                                        <SourceOrganismId>10090</SourceOrganismId>
                                    </Chain1>
                                    <Chain2>
                                        <Molecule>
                                            <GenBankId>1MFA_L</GenBankId>
                                        </Molecule>
                                        <SourceOrganismId>10090</SourceOrganismId>
                                    </Chain2>
                                </MultiChainMolecule>
                            </AssayedAntibodyObject>
                        </AssayedAntibody>
                        <Antigen>
                            <AntigenConformation>Non-Native/Unknown</AntigenConformation>
                            <AntigenObject>
                                <EpitopeRelation>Epitope</EpitopeRelation>
                                <Object>
                                    <FragmentOfANaturalNonSequenceMolecule>
                                        <ChemicalType>Carbohydrate fragment</ChemicalType>
                                        <Molecule>
                                            <ChEBIId>CHEBI:59319</ChEBIId>
                                        </Molecule>
                                        <SourceMolecule>
                                            <ChEBIId>CHEBI:16412</ChEBIId>
                                        </SourceMolecule>
                                        <SourceOrganismId>29477</SourceOrganismId>
                                    </FragmentOfANaturalNonSequenceMolecule>
                                </Object>
                            </AntigenObject>
                            <AntigenEvidenceCode>Exact match to reference information</AntigenEvidenceCode>
                        </Antigen>
                        <ThreeDimensionalStructureOfComplex>
                            <ComplexPdbId>1MFA</ComplexPdbId>
                            <AntibodyChain1PdbChain>H</AntibodyChain1PdbChain>
                            <AntibodyChain2PdbChain>L</AntibodyChain2PdbChain>
                            <AntigenChainPdbChain>H</AntigenChainPdbChain>
                            <ViewerFlag>Y</ViewerFlag>
                            <Comments>Paratope and antigen-antibody contacts are not provided in the paper. Antigen (trisaccharide) assumes different conformation (position of Gal residue) in complex with scFv (this structure) and Fab [PDB: 1MFD, 1MFE]. The intramolecular hydrogen bond AbeO2-GalO2, observed in complexes with Fab, doesn't exist in this complex.</Comments>
                            <CuratedContacts>
                                <EpitopeResidues>H: (GLA)501, (MMA)502, (ABE)503</EpitopeResidues>
                                <AntibodyResiduesInteractingWithAntigen>H: ; L: ;</AntibodyResiduesInteractingWithAntigen>
                            </CuratedContacts>
                            <CalculatedContacts>
                                <EpitopeResidues>H: (GLA)501, (MMA)502, (ABE)503</EpitopeResidues>
                                <AntibodyResiduesInteractingWithAntigen>H: W283, H285, F309, G350, H351, G352; L: H34, W93, N96, W98</AntibodyResiduesInteractingWithAntigen>
                                <ContactAreaForAntigen>358.4</ContactAreaForAntigen>
                                <ContactAreaForAntibody>246.1</ContactAreaForAntibody>
                            </CalculatedContacts>
                        </ThreeDimensionalStructureOfComplex>
                    </BCell>
                </Assays>
            </Epitope>
        </Epitopes>
    </Reference>
</References>

